Impact of Multimodal Diagnostic Assessment of Cerebral Gliomas With F-18-fluoroethyl-L-tyrosine PET/CT, F-18-fluorocholine PET/CT and Magnetic Resonance Imaging and Spectroscopy
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Glioma
Both
Glioma
Trial Information
Impact of Multimodal Diagnostic Assessment of Cerebral Gliomas With F-18-fluoroethyl-L-tyrosine PET/CT, F-18-fluorocholine PET/CT and Magnetic Resonance Imaging and Spectroscopy
Inclusion Criteria:
- Suspicion of intracerebral glioma on MR
- Men of women
- Age >18, no upper limit as long as a biopsy or intervention is foreseen
Exclusion Criteria:
- Need of rapid intervention in <2 weeks
- Previous neurosurgical intervention (biopsy, shunt, etc.) or any other cerebral
treatment
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Ability of image-guided biopsy using FET, FCH PET/CT and MRS information to target the most representative sites of tumor grade as compared to histopathological examination
Outcome Time Frame:
On the biopsy day
Safety Issue:
No
Principal Investigator
John O Prior, PhD MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Centre Hospitalier Universitaire Vaudois and University of Lausanne
Authority:
Switzerland: Federal Office of Public Health
Study ID:
196/08
NCT ID:
NCT00939315
Start Date:
July 2009
Completion Date:
December 2012
Related Keywords:
- Glioma
- Glioma, diagnosis
- Imaging
- Positron emission tomography
- Magnetic resonance imaging
- Magnetic resonance spectroscopy
- Glioma
Name | Location |
|---|
